MOTS-c

MOTS-c is distinguished from other peptides in this catalog by its unique biological origin: it is a mitochondrial-derived peptide, encoded by a small open reading frame within the mitochondrial genome rather than by nuclear DNA. This fundamental difference places it in a distinct class of signaling molecules. Discovered in 2015 by a research group led by Pinchas Cohen and Changhan Lee at the University of Southern California, MOTS-c emerged from investigations into the signaling roles of molecules produced by mitochondria. As an endogenous peptide, its existence highlights a novel layer of communication between the cell's powerhouses and the rest of the cellular machinery.

The primary interest in tracking MOTS-c protocols stems from its researched role in metabolic homeostasis. Scientific literature has framed its function around the regulation of cellular energy, particularly through pathways sensitive to nutrient and energy status. Personal tracking logs often focus on documenting its administration relative to metabolic state, diet, and exercise. Because it originates within the mitochondrion, it is often studied in contexts involving cellular stress, adaptation, and energy expenditure, providing a unique variable for individuals monitoring their metabolic parameters.

The peptide MOTS-c was first described by researchers Changhan Lee, Pinchas Cohen, and their colleagues at the University of Southern California. Its discovery was detailed in a 2015 paper published in *Cell Metabolism*. A key distinction of MOTS-c is its origin; it is encoded by a small open reading frame within the 12S rRNA region of mitochondrial DNA. This makes it the only known peptide with a mitochondrial genome origin that is studied for its systemic signaling functions.

Its origin from the mitochondrion positions it as a unique signaling molecule in cellular biology research. Unlike most peptides encoded in the cell's nucleus, MOTS-c originates from the organelle responsible for energy production. This allows it to function as a messenger that can communicate the metabolic state of the mitochondria to the nucleus and other parts of the cell. This process, known as mitonuclear communication, is a central focus in studies that observe the peptide's cellular interactions.

Research into MOTS-c's mechanism has consistently highlighted its interaction with the AMP-activated protein kinase (AMPK) pathway. AMPK functions as a master regulator of cellular energy balance, activated during states of low energy (high AMP:ATP ratio) to switch on catabolic processes and switch off anabolic, energy-consuming processes. Studies in various cell and animal models have observed that MOTS-c can influence AMPK activation. This interaction provides a molecular basis for the peptide's observed effects on glucose utilization and fatty acid oxidation in experimental settings. Its action on this critical energy-sensing pathway is central to its scientific characterization and the rationale for its study in metabolic contexts.

Scientific literature documents the interaction between MOTS-c and the AMP-activated protein kinase (AMPK) pathway. As a key cellular energy sensor, the AMPK pathway is a subject of study for its role in responding to metabolic stressors like exercise or caloric restriction. Research protocols are often designed to observe how MOTS-c may influence this pathway's activity. For this reason, MOTS-c is sometimes grouped with exercise mimetics in research contexts, and individuals can use tracking tools to document relevant observations.

Published research and user-documented protocols frequently describe an administration schedule of three times per week or on an every-other-day basis. This cadence is notably different from daily or weekly routines, introducing a significant variable for tracking adherence. The administration itself is typically documented as a subcutaneous injection, using a standard U-100 insulin syringe for measurement and delivery. Due to the relatively large dose size often studied, the choice of final concentration after reconstitution becomes an important practical consideration.

The timing of administration is another variable that individuals may choose to document in a personal log. Some experimental designs have explored the administration of MOTS-c in relation to physical activity, with the goal of studying its influence on exercise-induced metabolic adaptations. Others have examined its effects relative to fasting or fed states. Consequently, a detailed personal log might record not only the dose and date but also the time of day and its proximity to meals or exercise sessions to observe any patterns over time.

Published research protocols often use specific, fixed administration schedules, such as every-other-day dosing, to create a controlled environment. The goal in a formal study is to standardize all inputs to accurately observe the effects of a single variable. In contrast, a personal tracking plan documented on a platform serves the purpose of individual record-keeping and auditing. Users can plan and log their own schedule, which may be structured to mirror a research protocol or adjusted based on personal documentation goals.

The process of reconstitution requires a precise calculation to ensure accurate dosing. For a standard 10 mg vial of MOTS-c, adding 2 mL of bacteriostatic water will dissolve the lyophilized powder and yield a final concentration of 5 mg per mL. To administer a 5 mg dose from this specific solution, one must draw exactly 1 mL of liquid. On a U-100 insulin syringe, where the 1 mL total capacity is marked as 100 units, this volume corresponds to a full draw of 100 units.

The volume of diluent used is a key variable that determines the final injection volume. A 5 mg dose, as in the example, is a substantial amount, and using 2 mL of diluent results in a large 1 mL injection. Some individuals may document using a smaller diluent volume, such as 1 mL, to create a more concentrated solution (10 mg/mL). In that case, the same 5 mg dose would require only 0.5 mL (50 units), a significantly smaller volume to inject. The calculator on this site allows for planning and documenting these variables to maintain a consistent and auditable record.

A key point to document when reconstituting MOTS-c is its commonly studied dose range. Published studies frequently observe doses in the milligram range (e.g., 5 mg), substantially higher than many peptides dosed in micrograms. This distinction necessitates careful calculation. For example, a 10 mg vial reconstituted with 2 mL results in a 5 mg/mL solution. A 5 mg illustrative dose is then 1 mL, or 100 units on a U-100 syringe. Accurately calculating this concentration is critical for correct documentation.

Before it is mixed with a diluent, the lyophilized powder form of MOTS-c is maintained in refrigerated conditions to preserve its structure. Once reconstituted with bacteriostatic water, the vial containing the solution should also be stored in a refrigerator. Users typically plan to expend the contents of the reconstituted vial over a planned duration, often documented as a period of several weeks, to align with their protocol's schedule.

The every-other-day or three-times-per-week cadence associated with MOTS-c presents a distinct tracking challenge compared to simpler schedules. This irregular pattern is uniquely susceptible to unintentional drift, where the intended frequency is not maintained over time. To counteract this, a meticulous log is essential for documenting the exact date and time of each administration. Such a detailed record is the only reliable method for retrospectively auditing the actual dosing schedule and observing its consistency, which is a primary goal of personal protocol tracking.

For a detailed personal log, one can track more than just the administration schedule. Given the research focus on energy homeostasis, individuals could document exercise-related metrics like endurance performance or perceived exertion levels. Other relevant data points to monitor might include body composition figures or subjective scores for daily energy. Documenting these variables alongside a MOTS-c schedule allows for a more comprehensive personal audit, revealing patterns that may be of interest for future review.